Ultragenyx Pharmaceutical Stock (NASDAQ: RARE) stock price, news, charts, stock research, profile.
You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) through any online brokerage.
Other companies in Ultragenyx Pharmaceutical’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), Alkermes (NASDAQ:ALKS) and TG Therapeutics (NASDAQ:TGTX).
Ultragenyx Pharmaceutical has a consensus price target of $93.54.
The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $44.22 last updated December 20, 2024 at 4:02 PM EST.
There are no upcoming dividends for Ultragenyx Pharmaceutical.
Ultragenyx Pharmaceutical’s Q4 earnings are confirmed for Thursday, February 13, 2025.
There is no upcoming split for Ultragenyx Pharmaceutical.
Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.